Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study

J. Drabek, O. Nyc, M. Krutova, J. Stovicek, J. Matejkova, R. Keil,

. 2015 ; 14 (-) : 55. [pub] 20151223

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NT14209 MZ0 CEP Register

BACKGROUND: Clostridium difficile infection (CDI) is a major cause of antibiotic-associated diarrhoea. Given an increasing CDI incidence and global spread of epidemic ribotypes, a 1-year study was performed to analyse the molecular characteristics of C. difficile isolates and associated clinical outcomes from patients diagnosed with CDI in the Internal Medicine department at University Hospital Motol, Prague from February 2013 to February 2014. RESULTS: A total of 85 unformed stool samples were analysed and CDI was laboratory confirmed in 30 patients (6.8 CDI cases per 10,000 patient bed days and 50.6 CDI cases per 10,000 admissions). The CDI recurrence rate within 3 months of treatment discontinuation was 13.3% (4/30). Mortality within 3 months after first CDI episode was 26.7% (8/30), with CDI the cause of death in two cases. 51.9% of C. difficile isolates belonged to PCR-ribotype 176. MLVA of ribotype 176 isolates revealed two clonal complexes formed by 10/14 isolates. ATLAS scores and Horn's index were higher in patients with ribotype 176 infections than with non-ribotype 176 infections. CONCLUSION: This study highlights the clinical relevance of C. difficile PCR-ribotype 176 and its capacity to spread within a healthcare facility.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16009896
003      
CZ-PrNML
005      
20181210110409.0
007      
ta
008      
160408s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12941-015-0114-0 $2 doi
024    7_
$a 10.1186/s12941-015-0114-0 $2 doi
035    __
$a (PubMed)26698842
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Drábek, Jiří $u Department of Internal Medicine, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, 150 06, V Uvalu 84, Praha 5, Prague, Czech Republic. jiri.drabek@lfmotol.cuni.cz. $7 xx0067365
245    10
$a Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study / $c J. Drabek, O. Nyc, M. Krutova, J. Stovicek, J. Matejkova, R. Keil,
520    9_
$a BACKGROUND: Clostridium difficile infection (CDI) is a major cause of antibiotic-associated diarrhoea. Given an increasing CDI incidence and global spread of epidemic ribotypes, a 1-year study was performed to analyse the molecular characteristics of C. difficile isolates and associated clinical outcomes from patients diagnosed with CDI in the Internal Medicine department at University Hospital Motol, Prague from February 2013 to February 2014. RESULTS: A total of 85 unformed stool samples were analysed and CDI was laboratory confirmed in 30 patients (6.8 CDI cases per 10,000 patient bed days and 50.6 CDI cases per 10,000 admissions). The CDI recurrence rate within 3 months of treatment discontinuation was 13.3% (4/30). Mortality within 3 months after first CDI episode was 26.7% (8/30), with CDI the cause of death in two cases. 51.9% of C. difficile isolates belonged to PCR-ribotype 176. MLVA of ribotype 176 isolates revealed two clonal complexes formed by 10/14 isolates. ATLAS scores and Horn's index were higher in patients with ribotype 176 infections than with non-ribotype 176 infections. CONCLUSION: This study highlights the clinical relevance of C. difficile PCR-ribotype 176 and its capacity to spread within a healthcare facility.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a antibakteriální látky $x aplikace a dávkování $x škodlivé účinky $7 D000900
650    _2
$a klostridiové infekce $x epidemiologie $x mikrobiologie $x mortalita $x patologie $7 D003015
650    _2
$a Clostridioides difficile $x klasifikace $x genetika $x izolace a purifikace $7 D016360
650    _2
$a průjem $x chemicky indukované $x epidemiologie $x mikrobiologie $x patologie $7 D003967
650    _2
$a feces $x mikrobiologie $7 D005243
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a nemocnice univerzitní $7 D006785
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a polymerázová řetězová reakce $7 D016133
650    _2
$a recidiva $7 D012008
650    12
$a ribotypizace $7 D021521
650    _2
$a analýza přežití $7 D016019
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Nyč, Otakar $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic. otakar.nyc@lfmotol.cuni.cz. $7 uk2007399535
700    1_
$a Krůtová, Marcela $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic. marcela.krutova@seznam.cz. DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic. marcela.krutova@seznam.cz. $7 xx0191653
700    1_
$a Šťovíček, Jan $u Department of Internal Medicine, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, 150 06, V Uvalu 84, Praha 5, Prague, Czech Republic. jan.stovicek@fnmotol.cz. $7 xx0093415
700    1_
$a Matějková, Jana $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic. jana.matejkova@lfmotol.cuni.cz. $7 xx0209775
700    1_
$a Keil, Radan, $u Department of Internal Medicine, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, 150 06, V Uvalu 84, Praha 5, Prague, Czech Republic. Radan.Keil@fnmotol.cz. $d 1961- $7 jn20000401330
773    0_
$w MED00008163 $t Annals of clinical microbiology and antimicrobials $x 1476-0711 $g Roč. 14, č. - (2015), s. 55
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26698842 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20181210110530 $b ABA008
999    __
$a ok $b bmc $g 1113325 $s 934264
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 14 $c - $d 55 $e 20151223 $i 1476-0711 $m Annals of clinical microbiology and antimicrobials $n Ann Clin Microbiol Antimicrob $x MED00008163
GRA    __
$a NT14209 $p MZ0
LZP    __
$a Pubmed-20160408

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...